{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT05005403",
      "orgStudyIdInfo": {
        "id": "M21-410"
      },
      "organization": {
        "fullName": "AbbVie",
        "class": "INDUSTRY"
      },
      "briefTitle": "Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab",
      "officialTitle": "A Global First-in-Human Study in NSCLC, HNSCC and Solid Tumors With Azirkitug (ABBV-514) as a Single Agent and in Combination With Budigalimab or Bevacizumab"
    },
    "statusModule": {
      "statusVerifiedDate": "2025-10",
      "overallStatus": "RECRUITING",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2021-11-01",
        "type": "ACTUAL"
      },
      "primaryCompletionDateStruct": {
        "date": "2026-07",
        "type": "ESTIMATED"
      },
      "completionDateStruct": {
        "date": "2027-06",
        "type": "ESTIMATED"
      },
      "studyFirstSubmitDate": "2021-08-12",
      "studyFirstSubmitQcDate": "2021-08-12",
      "studyFirstPostDateStruct": {
        "date": "2021-08-13",
        "type": "ACTUAL"
      },
      "lastUpdateSubmitDate": "2025-10-27",
      "lastUpdatePostDateStruct": {
        "date": "2025-10-28",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "AbbVie",
        "class": "INDUSTRY"
      }
    },
    "oversightModule": {
      "oversightHasDmc": false,
      "isFdaRegulatedDrug": true,
      "isFdaRegulatedDevice": false,
      "isUsExport": false
    },
    "descriptionModule": {
      "briefSummary": "Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. Head and Neck Squamous Cell Carcinoma (HNSCC) is a solid tumor, a disease in which cancer cells form in the tissues of the head and neck. The purpose of this study is to assess adverse events and pharmacokinetics of Azirkitug (ABBV-514) as a monotherapy and in combination with Budigalimab or Bevacizumab,.\n\nBevacizumab is an approved product, while Budigalimab and Azirkitug (ABBV-514) are investigational drugs being developed for the treatment of NSCLC, HNSCC, and other solid tumors. Study doctors put the participants in groups called treatment arms. The maximum-tolerated dose (MTD)/maximum administered dose (MAD) of Azirkitug (ABBV-514) will be explored. Each treatment arm receives a different dose of Azirkitug (ABBV-514) in monotherapy and in combination with Budigalimab or Bevacizumab. Approximately 512 adult participants will be enrolled in the study across approximately 80 sites worldwide.\n\nParticipants will receive Azirkitug (ABBV-514) as a monotherapy or in combination with Budigalimab or Bevacizumab as an Intravenous (IV) Infusion for an estimated treatment period of up to 2 years.\n\nThere may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires."
    },
    "conditionsModule": {
      "conditions": [
        "Non-Small Cell Lung Cancer",
        "Head and Neck Squamous Cell Carcinoma",
        "Micro Satellite Stable Colorectal Cancer",
        "Gastric/Esophageal Cancer",
        "High-Grade Serous Ovarian Cancer",
        "Pancreatic Cancer",
        "Triple Negative Breast Cancer"
      ],
      "keywords": [
        "Non-Small Cell Lung Cancer",
        "NSCLC",
        "Head and Neck Squamous Cell Carcinoma",
        "HNSCC",
        "Solid Tumors",
        "Budigalimab",
        "ABBV-181",
        "ABBV-514",
        "Micro Satellite Stable Colorectal Cancer",
        "MSS-CRC, Gastric Cancer",
        "Esophageal Cancer",
        "GEA",
        "GEJ",
        "High-Grade Serous Ovarian Cancer",
        "HGSOC",
        "Pancreatic Cancer, PDAC",
        "Triple Negative Breast Cancer",
        "TNBC"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "designInfo": {
        "allocation": "NON_RANDOMIZED",
        "interventionModel": "SEQUENTIAL",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "NONE"
        }
      },
      "enrollmentInfo": {
        "count": 512,
        "type": "ESTIMATED"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "Part 1 Dose Escalation: Azirkitug (ABBV-514)",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive Azirkitug (ABBV-514).",
          "interventionNames": [
            "Drug: Azirkitug"
          ]
        },
        {
          "label": "Part 1 Dose Escalation: Azirkitug (ABBV-514) + Budigalimab",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive Azirkitug (ABBV-514) in combination with budigalimab.",
          "interventionNames": [
            "Drug: Azirkitug",
            "Drug: Budigalimab"
          ]
        },
        {
          "label": "Part 2 Dose Expansion: Azirkitug (ABBV-514)",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive Azirkitug (ABBV-514) at recommended dose determined in Dose Escalation portion.",
          "interventionNames": [
            "Drug: Azirkitug"
          ]
        },
        {
          "label": "Part 2 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive Azirkitug (ABBV-514) at recommended dose determined in Dose Escalation portion in combination with budigalimab.",
          "interventionNames": [
            "Drug: Azirkitug",
            "Drug: Budigalimab"
          ]
        },
        {
          "label": "Part 3 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive Azirkitug (ABBV-514) at recommended dose determined in Dose Escalation portion in combination with budigalimab.",
          "interventionNames": [
            "Drug: Azirkitug",
            "Drug: Budigalimab"
          ]
        },
        {
          "label": "Part 4 Dose Expansion: Azirkitug (ABBV-514)",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive Azirkitug (ABBV-514) at recommended dose determined in Dose Escalation portion.",
          "interventionNames": [
            "Drug: Azirkitug"
          ]
        },
        {
          "label": "Part 4 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive Azirkitug (ABBV-514) at recommended dose determined in Dose Escalation portion in combination with budigalimab.",
          "interventionNames": [
            "Drug: Azirkitug",
            "Drug: Budigalimab"
          ]
        },
        {
          "label": "Part 5 Dose Expansion: Azirkitug (ABBV-514)",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive Azirkitug (ABBV-514) at recommended dose determined in Dose Escalation portion.",
          "interventionNames": [
            "Drug: Azirkitug"
          ]
        },
        {
          "label": "Part 5 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive Azirkitug (ABBV-514) at recommended dose determined in Dose Escalation portion in combination with budigalimab.",
          "interventionNames": [
            "Drug: Azirkitug",
            "Drug: Budigalimab"
          ]
        },
        {
          "label": "Part 6 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive Azirkitug (ABBV-514) at recommended dose determined in Dose Escalation portion in combination with budigalimab.",
          "interventionNames": [
            "Drug: Azirkitug",
            "Drug: Budigalimab"
          ]
        },
        {
          "label": "Part 7 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive Azirkitug (ABBV-514) at recommended dose determined in Dose Escalation portion in combination with budigalimab.",
          "interventionNames": [
            "Drug: Azirkitug",
            "Drug: Budigalimab"
          ]
        },
        {
          "label": "Part 8 Dose Escalation: Azirkitug (ABBV-514) + Bevacizumab",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive Azirkitug (ABBV-514) in combination with bevacizumab.",
          "interventionNames": [
            "Drug: Azirkitug",
            "Drug: Bevacizumab"
          ]
        },
        {
          "label": "Part 8 Dose Expansion: Azirkitug (ABBV-514) + Bevacizumab",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive Azirkitug (ABBV-514) at recommended dose determined in Dose Escalation portion in combination with bevacizumab.",
          "interventionNames": [
            "Drug: Azirkitug",
            "Drug: Bevacizumab"
          ]
        },
        {
          "label": "Part 9 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
          "type": "EXPERIMENTAL",
          "description": "Participants will receive Azirkitug (ABBV-514) at recommended dose determined in Dose Escalation portion in combination with budigalimab.",
          "interventionNames": [
            "Drug: Azirkitug",
            "Drug: Budigalimab"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "Azirkitug",
          "description": "Intravenous (IV) Infusion",
          "armGroupLabels": [
            "Part 1 Dose Escalation: Azirkitug (ABBV-514)",
            "Part 1 Dose Escalation: Azirkitug (ABBV-514) + Budigalimab",
            "Part 2 Dose Expansion: Azirkitug (ABBV-514)",
            "Part 2 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
            "Part 3 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
            "Part 4 Dose Expansion: Azirkitug (ABBV-514)",
            "Part 4 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
            "Part 5 Dose Expansion: Azirkitug (ABBV-514)",
            "Part 5 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
            "Part 6 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
            "Part 7 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
            "Part 8 Dose Escalation: Azirkitug (ABBV-514) + Bevacizumab",
            "Part 8 Dose Expansion: Azirkitug (ABBV-514) + Bevacizumab",
            "Part 9 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab"
          ],
          "otherNames": [
            "ABBV-514"
          ]
        },
        {
          "type": "DRUG",
          "name": "Budigalimab",
          "description": "Intravenous (IV) Infusion",
          "armGroupLabels": [
            "Part 1 Dose Escalation: Azirkitug (ABBV-514) + Budigalimab",
            "Part 2 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
            "Part 3 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
            "Part 4 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
            "Part 5 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
            "Part 6 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
            "Part 7 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab",
            "Part 9 Dose Expansion: Azirkitug (ABBV-514) + Budigalimab"
          ],
          "otherNames": [
            "ABBV-181"
          ]
        },
        {
          "type": "DRUG",
          "name": "Bevacizumab",
          "description": "Intravenous (IV) Infusion",
          "armGroupLabels": [
            "Part 8 Dose Escalation: Azirkitug (ABBV-514) + Bevacizumab",
            "Part 8 Dose Expansion: Azirkitug (ABBV-514) + Bevacizumab"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Number of Participants with Adverse Events (AE)",
          "description": "An AE is defined as any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment.",
          "timeFrame": "Up to 2 Years"
        },
        {
          "measure": "Maximum Observed Serum Concentration (Cmax) of ABBV-514",
          "description": "Maximum Observed Serum Concentration (Cmax) of of ABBV-514.",
          "timeFrame": "Up to 2 Years"
        },
        {
          "measure": "Time to Maximum Observed Serum Concentration (Tmax) of ABBV-514",
          "description": "Time to maximum Observed Serum Concentration (Tmax) of of ABBV-514.",
          "timeFrame": "Up to 2 Years"
        },
        {
          "measure": "Terminal Elimination Half-Life (t1/2) of ABBV-514",
          "description": "Terminal elimination half-life (t1/2) of ABBV-514.",
          "timeFrame": "Up to 2 Years"
        },
        {
          "measure": "Area Under the Serum Concentration Versus Time Curve (AUC) of ABBV-514",
          "description": "Area under the serum concentration versus time curve (AUC) of ABBV-514.",
          "timeFrame": "Up to 2 Years"
        },
        {
          "measure": "Antidrug Antibody (ADA)",
          "description": "Incidence and concentration of anti-drug antibodies.",
          "timeFrame": "Up to 2 Years"
        },
        {
          "measure": "Neutralizing Antidrug Antibody (nADA)",
          "description": "Incidence and concentration of neutralizing anti-drug antibodies.",
          "timeFrame": "Up to 2 Years"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Pre Treatment biopsy or archive tissue within 6 months without intervening treatment\n* Eastern Cooperative Oncology Group (ECOG) performance status of \\<=1\n* Measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST)\n* Laboratory values meeting criteria outlined in the protocol\n* NSCLC - Advanced or metastatic progressed on standard of care (SOC) including chemotherapy and prior anti-PD-(L)1 antibody (separately or in combination). Actionable gene alterations are eligible if failed targeted therapeutic options.\n* HSNCC - Advanced/metastatic progressed on platinum and PD-1/PD-LI in recurrent or metastatic setting.\n* Micro Satellite Stable Colorectal Cancer (MSS-CRC) - Progressed on Oxaliplatin, Irinotecan, a fluoropyrimidine, anti-EGFR, VEGF or VEGFR therapies, TAS-102, Regorafenib and not MSI-h or MMR-deficient\n* Gastric and Gastroesophageal Junction adenocarcinoma (GEA) - Advanced/metastatic progressed on at least 1 prior cytotoxic chemotherapeutic regimen and if applicable immune checkpoint inhibitor and/or HER2 therapy\n* High-Grade Serous Ovarian Cancer (HGSOC) - Progressed serous epithelial ovarian, fallopian tube or primary peritoneal cancer post SOC and not eligible for surgical resection. Platinum resistant cannot have \\>5 lines of prior therapy.\n* Pancreatic Adenocarcinoma (PDAC) - Advanced/metastatic progressed after SOC. Includes adenosquamous carcinoma and post-Whipple.\n* Triple Negative Breast Cancer (TNBC) - Progressed after \\>1 systemic therapy that must have included taxane and treatment naïve to immunotherapy targeting T-cell co-stimulation\n\nExclusion Criteria:\n\n* Pancreatic Ductal Adenocarcinoma (PDAC) - Excludes neuroendocrine or acinar pancreatic carcinoma and participants with coagulopathy or at risk of or history of Deep vein thrombosis (DVT)/PE\n* No major surgery within 28 days prior to dosing\n* No active autoimmune/immunodeficiency disease with limited exceptions\n* Combination treatment excludes participants treated with anti-programmed cell death protein 1(PD-1)/Programmed cell death ligand 1 (PD-L1) who had immune mediated toxicity G3 or greater, interstitial lung disease, or hypersensitivity Combination treatment may also require no significant cardiac deficiencies and/or events\n* Pregnancy\n* Excluded medications include anticancer therapy within 5 half-live or 28 days (whichever is shorter), agent targeting Chemokine Receptor (CCR)8, live vaccines, immunosuppressive medication with limited exceptions",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "stdAges": [
        "ADULT",
        "OLDER_ADULT"
      ]
    },
    "contactsLocationsModule": {
      "centralContacts": [
        {
          "name": "ABBVIE CALL CENTER",
          "role": "CONTACT",
          "phone": "844-663-3742",
          "email": "abbvieclinicaltrials@abbvie.com"
        }
      ],
      "overallOfficials": [
        {
          "name": "ABBVIE INC.",
          "affiliation": "AbbVie",
          "role": "STUDY_DIRECTOR"
        }
      ],
      "locations": [
        {
          "facility": "City of Hope National Medical Center /ID# 276272",
          "status": "RECRUITING",
          "city": "Duarte",
          "state": "California",
          "zip": "91010",
          "country": "United States",
          "geoPoint": {
            "lat": 34.13945,
            "lon": -117.97729
          }
        },
        {
          "facility": "University of Illinois Hospital and Health Sciences System /ID# 251750",
          "status": "RECRUITING",
          "city": "Chicago",
          "state": "Illinois",
          "zip": "60607",
          "country": "United States",
          "geoPoint": {
            "lat": 41.85003,
            "lon": -87.65005
          }
        },
        {
          "facility": "Fort Wayne Medical Oncology and Hematology, Inc /ID# 232593",
          "status": "RECRUITING",
          "city": "Fort Wayne",
          "state": "Indiana",
          "zip": "46804",
          "country": "United States",
          "geoPoint": {
            "lat": 41.1306,
            "lon": -85.12886
          }
        },
        {
          "facility": "Community Health Network, Inc. /ID# 243011",
          "status": "RECRUITING",
          "city": "Indianapolis",
          "state": "Indiana",
          "zip": "46250-2042",
          "country": "United States",
          "geoPoint": {
            "lat": 39.76838,
            "lon": -86.15804
          }
        },
        {
          "facility": "Norton Cancer Institute /ID# 248903",
          "status": "RECRUITING",
          "city": "Louisville",
          "state": "Kentucky",
          "zip": "40241-2832",
          "country": "United States",
          "geoPoint": {
            "lat": 38.25424,
            "lon": -85.75941
          }
        },
        {
          "facility": "START Midwest /ID# 248685",
          "status": "RECRUITING",
          "city": "Grand Rapids",
          "state": "Michigan",
          "zip": "49546-7062",
          "country": "United States",
          "geoPoint": {
            "lat": 42.96336,
            "lon": -85.66809
          }
        },
        {
          "facility": "Nebraska Cancer Specialists - Omaha - Wright Street /ID# 247399",
          "status": "RECRUITING",
          "city": "Omaha",
          "state": "Nebraska",
          "zip": "68130",
          "country": "United States",
          "geoPoint": {
            "lat": 41.25626,
            "lon": -95.94043
          }
        },
        {
          "facility": "Carolina BioOncology Institute /ID# 232597",
          "status": "RECRUITING",
          "city": "Huntersville",
          "state": "North Carolina",
          "zip": "28078",
          "country": "United States",
          "contacts": [
            {
              "name": "Site Coordinator",
              "role": "CONTACT",
              "phone": "844-663-3742"
            }
          ],
          "geoPoint": {
            "lat": 35.41069,
            "lon": -80.84285
          }
        },
        {
          "facility": "NEXT Oncology Austin /ID# 243005",
          "status": "RECRUITING",
          "city": "Austin",
          "state": "Texas",
          "zip": "78705-1171",
          "country": "United States",
          "geoPoint": {
            "lat": 30.26715,
            "lon": -97.74306
          }
        },
        {
          "facility": "The University of Texas MD Anderson Cancer Center /ID# 270059",
          "status": "RECRUITING",
          "city": "Houston",
          "state": "Texas",
          "zip": "77030",
          "country": "United States",
          "geoPoint": {
            "lat": 29.76328,
            "lon": -95.36327
          }
        },
        {
          "facility": "NEXT Oncology /ID# 243007",
          "status": "RECRUITING",
          "city": "San Antonio",
          "state": "Texas",
          "zip": "78229",
          "country": "United States",
          "geoPoint": {
            "lat": 29.42412,
            "lon": -98.49363
          }
        },
        {
          "facility": "South Texas Accelerated Research Therapeutics (START) /ID# 276268",
          "status": "RECRUITING",
          "city": "San Antonio",
          "state": "Texas",
          "zip": "78229",
          "country": "United States",
          "geoPoint": {
            "lat": 29.42412,
            "lon": -98.49363
          }
        },
        {
          "facility": "Start Mountain Region /ID# 276270",
          "status": "RECRUITING",
          "city": "West Valley City",
          "state": "Utah",
          "zip": "84119",
          "country": "United States",
          "geoPoint": {
            "lat": 40.69161,
            "lon": -112.00105
          }
        },
        {
          "facility": "Virginia Cancer Specialists - Fairfax /ID# 232592",
          "status": "RECRUITING",
          "city": "Fairfax",
          "state": "Virginia",
          "zip": "22031",
          "country": "United States",
          "geoPoint": {
            "lat": 38.84622,
            "lon": -77.30637
          }
        },
        {
          "facility": "The Chaim Sheba Medical Center /ID# 238332",
          "status": "RECRUITING",
          "city": "Ramat Gan",
          "state": "Tel Aviv",
          "zip": "5265601",
          "country": "Israel",
          "geoPoint": {
            "lat": 32.08227,
            "lon": 34.81065
          }
        },
        {
          "facility": "Rambam Health Care Campus /ID# 238333",
          "status": "RECRUITING",
          "city": "Haifa",
          "zip": "3109601",
          "country": "Israel",
          "geoPoint": {
            "lat": 32.81303,
            "lon": 34.99928
          }
        },
        {
          "facility": "Hadassah Medical Center-Hebrew University /ID# 252287",
          "status": "RECRUITING",
          "city": "Jerusalem",
          "zip": "91120",
          "country": "Israel",
          "geoPoint": {
            "lat": 31.76904,
            "lon": 35.21633
          }
        },
        {
          "facility": "Rabin Medical Center /ID# 250497",
          "status": "RECRUITING",
          "city": "Petah Tikva",
          "zip": "4941492",
          "country": "Israel",
          "geoPoint": {
            "lat": 32.08707,
            "lon": 34.88747
          }
        },
        {
          "facility": "Aichi Cancer Center Hospital /ID# 250405",
          "status": "RECRUITING",
          "city": "Nagoya",
          "state": "Aichi-ken",
          "zip": "464-8681",
          "country": "Japan",
          "geoPoint": {
            "lat": 35.18147,
            "lon": 136.90641
          }
        },
        {
          "facility": "National Cancer Center Hospital East /ID# 238840",
          "status": "RECRUITING",
          "city": "Kashiwa-shi",
          "state": "Chiba",
          "zip": "277-8577",
          "country": "Japan"
        },
        {
          "facility": "Kobe University Hospital /ID# 250409",
          "status": "RECRUITING",
          "city": "Kobe",
          "state": "Hyōgo",
          "zip": "650-0017",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.6913,
            "lon": 135.183
          }
        },
        {
          "facility": "Kansai Medical University Hospital /ID# 276805",
          "status": "RECRUITING",
          "city": "Hirakata-shi",
          "state": "Osaka",
          "zip": "573-1191",
          "country": "Japan"
        },
        {
          "facility": "Shizuoka Cancer Center /ID# 250408",
          "status": "RECRUITING",
          "city": "Sunto-gun",
          "state": "Shizuoka",
          "zip": "411-8777",
          "country": "Japan"
        },
        {
          "facility": "National Cancer Center Hospital /ID# 238372",
          "status": "RECRUITING",
          "city": "Chuo-ku",
          "state": "Tokyo",
          "zip": "104-0045",
          "country": "Japan"
        },
        {
          "facility": "Wakayama Medical University Hospital /ID# 276806",
          "status": "RECRUITING",
          "city": "Wakayama",
          "state": "Wakayama",
          "zip": "641-8510",
          "country": "Japan",
          "geoPoint": {
            "lat": 34.23333,
            "lon": 135.16667
          }
        },
        {
          "facility": "National Cancer Center /ID# 252290",
          "status": "RECRUITING",
          "city": "Goyang-si",
          "state": "Gyeonggido",
          "zip": "10408",
          "country": "South Korea",
          "geoPoint": {
            "lat": 37.65639,
            "lon": 126.835
          }
        },
        {
          "facility": "CHA Bundang Medical Center /ID# 252291",
          "status": "RECRUITING",
          "city": "Seongnam",
          "state": "Gyeonggido",
          "zip": "13496",
          "country": "South Korea",
          "geoPoint": {
            "lat": 35.54127,
            "lon": 127.39683
          }
        },
        {
          "facility": "Yonsei University Health System Severance Hospital /ID# 252288",
          "status": "RECRUITING",
          "city": "Seoul",
          "state": "Seoul Teugbyeolsi",
          "zip": "03722",
          "country": "South Korea",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "Asan Medical Center /ID# 252289",
          "status": "RECRUITING",
          "city": "Seoul",
          "state": "Seoul Teugbyeolsi",
          "zip": "05505",
          "country": "South Korea",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "The Catholic University of Korea, Seoul St. Marys Hospital /ID# 252867",
          "status": "RECRUITING",
          "city": "Seoul",
          "state": "Seoul Teugbyeolsi",
          "zip": "06591",
          "country": "South Korea",
          "geoPoint": {
            "lat": 37.566,
            "lon": 126.9784
          }
        },
        {
          "facility": "National Taiwan University Hospital /ID# 251894",
          "status": "RECRUITING",
          "city": "Taipei City",
          "state": "Taipei",
          "zip": "100",
          "country": "Taiwan"
        },
        {
          "facility": "Taipei Medical University Shuang Ho Hospital /ID# 252449",
          "status": "RECRUITING",
          "city": "New Taipei City",
          "zip": "23561",
          "country": "Taiwan",
          "geoPoint": {
            "lat": 25.06199,
            "lon": 121.45703
          }
        },
        {
          "facility": "National Cheng Kung University Hospital /ID# 252262",
          "status": "RECRUITING",
          "city": "Tainan",
          "zip": "704",
          "country": "Taiwan",
          "geoPoint": {
            "lat": 22.99083,
            "lon": 120.21333
          }
        },
        {
          "facility": "Taipei Medical University Hospital /ID# 252450",
          "status": "RECRUITING",
          "city": "Taipei",
          "zip": "11031",
          "country": "Taiwan",
          "geoPoint": {
            "lat": 25.05306,
            "lon": 121.52639
          }
        },
        {
          "facility": "Tri-Service General Hospital /ID# 252263",
          "status": "RECRUITING",
          "city": "Taipei",
          "zip": "11490",
          "country": "Taiwan",
          "geoPoint": {
            "lat": 25.05306,
            "lon": 121.52639
          }
        }
      ]
    },
    "ipdSharingStatementModule": {
      "ipdSharing": "NO"
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-20"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D002289",
          "term": "Carcinoma, Non-Small-Cell Lung"
        },
        {
          "id": "D000077195",
          "term": "Squamous Cell Carcinoma of Head and Neck"
        },
        {
          "id": "D004938",
          "term": "Esophageal Neoplasms"
        },
        {
          "id": "D010190",
          "term": "Pancreatic Neoplasms"
        },
        {
          "id": "D064726",
          "term": "Triple Negative Breast Neoplasms"
        },
        {
          "id": "D013274",
          "term": "Stomach Neoplasms"
        },
        {
          "id": "C537768",
          "term": "Anophthalmia with pulmonary hypoplasia"
        }
      ],
      "ancestors": [
        {
          "id": "D002283",
          "term": "Carcinoma, Bronchogenic"
        },
        {
          "id": "D001984",
          "term": "Bronchial Neoplasms"
        },
        {
          "id": "D008175",
          "term": "Lung Neoplasms"
        },
        {
          "id": "D012142",
          "term": "Respiratory Tract Neoplasms"
        },
        {
          "id": "D013899",
          "term": "Thoracic Neoplasms"
        },
        {
          "id": "D009371",
          "term": "Neoplasms by Site"
        },
        {
          "id": "D009369",
          "term": "Neoplasms"
        },
        {
          "id": "D008171",
          "term": "Lung Diseases"
        },
        {
          "id": "D012140",
          "term": "Respiratory Tract Diseases"
        },
        {
          "id": "D002294",
          "term": "Carcinoma, Squamous Cell"
        },
        {
          "id": "D002277",
          "term": "Carcinoma"
        },
        {
          "id": "D009375",
          "term": "Neoplasms, Glandular and Epithelial"
        },
        {
          "id": "D009370",
          "term": "Neoplasms by Histologic Type"
        },
        {
          "id": "D006258",
          "term": "Head and Neck Neoplasms"
        },
        {
          "id": "D005770",
          "term": "Gastrointestinal Neoplasms"
        },
        {
          "id": "D004067",
          "term": "Digestive System Neoplasms"
        },
        {
          "id": "D004066",
          "term": "Digestive System Diseases"
        },
        {
          "id": "D004935",
          "term": "Esophageal Diseases"
        },
        {
          "id": "D005767",
          "term": "Gastrointestinal Diseases"
        },
        {
          "id": "D004701",
          "term": "Endocrine Gland Neoplasms"
        },
        {
          "id": "D010182",
          "term": "Pancreatic Diseases"
        },
        {
          "id": "D004700",
          "term": "Endocrine System Diseases"
        },
        {
          "id": "D001943",
          "term": "Breast Neoplasms"
        },
        {
          "id": "D001941",
          "term": "Breast Diseases"
        },
        {
          "id": "D012871",
          "term": "Skin Diseases"
        },
        {
          "id": "D017437",
          "term": "Skin and Connective Tissue Diseases"
        },
        {
          "id": "D013272",
          "term": "Stomach Diseases"
        }
      ]
    },
    "interventionBrowseModule": {
      "meshes": [
        {
          "id": "C000719868",
          "term": "budigalimab"
        },
        {
          "id": "D000068258",
          "term": "Bevacizumab"
        }
      ],
      "ancestors": [
        {
          "id": "D061067",
          "term": "Antibodies, Monoclonal, Humanized"
        },
        {
          "id": "D000911",
          "term": "Antibodies, Monoclonal"
        },
        {
          "id": "D000906",
          "term": "Antibodies"
        },
        {
          "id": "D007136",
          "term": "Immunoglobulins"
        },
        {
          "id": "D007162",
          "term": "Immunoproteins"
        },
        {
          "id": "D001798",
          "term": "Blood Proteins"
        },
        {
          "id": "D011506",
          "term": "Proteins"
        },
        {
          "id": "D000602",
          "term": "Amino Acids, Peptides, and Proteins"
        },
        {
          "id": "D012712",
          "term": "Serum Globulins"
        },
        {
          "id": "D005916",
          "term": "Globulins"
        }
      ]
    }
  },
  "hasResults": false
}